Shares of Cellebrite DI Ltd. (NASDAQ:CLBT) surged over 9% in pre-market trading on Monday, after the digital intelligence company reported better-than-expected results for the third quarter of 2024 and raised its full-year outlook.
For Q3, Cellebrite posted adjusted earnings of $0.14 per share, beating analysts' consensus estimate of $0.09 by a wide margin. Revenue came in at $106.86 million, up nearly 27% year-over-year and surpassing expectations of $101.93 million.
Buoyed by the strong quarterly performance, Cellebrite raised its revenue guidance for the full year 2024 to a range of $397 million to $401 million, up from its prior outlook. The company also lifted its adjusted EBITDA forecast for the year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.